ITEOS THERAPEUTICS IN

iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

07 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

iTeos to Participate in Upcoming Investor Conferences

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates

08 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates

10 May 2023 07:01:00 By Nasdaq GlobeNewswire

iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

15 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

iTeos to Present at SVB Securities Global Biopharma Conference

07 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

iTeos Provides Business Updates and Clinical Development Plans for 2023

09 Jan 2023 07:00:02 By Nasdaq GlobeNewswire

iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference

22 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates

10 Nov 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update

10 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference

02 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

iTeos Reports First Quarter 2022 Financial Results and Provides Business Update

12 May 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022

08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire

iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

23 Mar 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos to Present at the Cowen 42nd Annual Health Care Conference

01 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

iTeos to Participate in Upcoming Investor Conferences in February

10 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer

10 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 16:01:00 By Nasdaq GlobeNewswire

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021

09 Dec 2021 16:01:00 By Nasdaq GlobeNewswire